References
- US Department of Health and Human Services. Policy for device software functions and mobile medical applications. Guidance for industry and food and drug administration staff. 2019 [cited 2020 Dec 22]. Available from: https://www.fda.gov/media/80958/download
- Research2guidance [Internet]. mHealth app developer economics. 2017 [cited 2020 Dec 17] Available from: https://research2guidance.com/mhealth-app-developer-economics/
- The Insight Partners [Internet]. mHealth market to 2025. 2018 [cited 2021 Jan 10]. Available from: https://www.theinsightpartners.com/reports/mhealth-market
- Business of Apps [Internet]. App download and usage statistics. 2020 Oct 30 [cited 2021 Jan 10]. Available from: https://www.businessofapps.com/data/app-statistics
- Armitage LC, Kassavou A, Sutton S. Do mobile device apps designed to support medication adherence demonstrate efficacy? A systematic review of randomised controlled trials, with meta-analysis. BMJ Open. 2020;10(1):e032045.
- Byambasuren O, Sanders S, Beller E, et al. Prescribable mHealth apps identified from an overview of systematic reviews. NPJ Digit Med. 2018;1:12.
- Wu X, Guo X, Zhang Z. The efficacy of mobile phone apps for lifestyle modification in diabetes: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2019;7(1):e12297.
- Tarricone R, Ciani O, Torbica A, et al. Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective. Expert Rev Med Devices. 2020;17(10):993–1006.
- Center for Devices & Radiological Health Digital Health Program. Digital health action plan. 2019 [cited 2020 Dec 22]. Available from: https://www.fda.gov/downloads/MedicalDevices/DigitalHealth/UCM568735.pdf
- Food & Drug Administration. Developing a software precertification program: a working model. 2019 [cited 2020 Dec 22]. Available from: https://www.fda.gov/downloads/MedicalDevices/DigitalHealth/DigitalHealthPreCertProgram/UCM629276.pdf
- Kasperbauer TJ, Wright DE. Expanded FDA regulation of health and wellness apps. Bioethics. 2020;34(3):235–241.
- Medical Device Coordination Group (MDCG). Guidance on qualification and classification of software in regulation (EU) 2017/745 – MDR and regulation (EU) 2017/746 – IVDR. 2019 [cited 2020 Dec 22]. Available from: https://ec.europa.eu/docsroom/documents/37581
- Medical Device Coordination Group (MDCG). Guidance on Clinical Evaluation (MDR)/Performance Evaluation (IVDR) of Medical Device Software. 2020 [cited 2020 Dec 22]. Available from: https://ec.europa.eu/docsroom/documents/40323
- International Medical Device Regulators Forum. Software as a medical device (SaMD): clinical evaluation. 2016 [cited 2020 Dec 22]. Available from: http://www.imdrf.org/docs/imdrf/final/consultations/imdrf-cons-samd-ce.pdf
- Rowland SP, Fitzgerald JE, Holme T, et al. What is the clinical value of mHealth for patients? NPJ Digit Med. 2020;3:4.
- Shuren J, Patel B, Gottlieb S. FDA regulation of mobile medical apps. JAMA. 2018;320(4):337–338.
- Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs–same or different? Value Health. 2009;12(4):402–404.
- Murray E, Hekler EB, Andersson G, et al. Evaluating digital health interventions: key questions and approaches. Am J Prev Med. 2016;51(5):843–851.
- Kumar S, Nilsen WJ, Abernethy A, et al. Mobile health technology evaluation: the mHealth evidence workshop. Am J Prev Med. 2013;45(2):228–236.
- Petticrew M, Anderson L, Elder R, et al. Complex interventions and their implications for systematic reviews: a pragmatic approach. Int J Nurs Stud. 2015;52(7):1211–1216.
- McNamee P, Murray E, Kelly MP, et al. Designing and undertaking a health economics study of digital health interventions. Am J Prev Med. 2016;51(5):852–860.
- Edwards EA, Lumsden J, Rivas C, et al. Gamification for health promotion: systematic review of behaviour change techniques in smartphone apps. BMJ Open. 2016;6(10):e012447.
- Marchal B, Westhorp G, Wong G, et al. Realist RCTs of complex interventions - an oxymoron. Soc Sci Med. 2013;94:124–128.
- Michie S, Yardley L, West R, et al. Developing and evaluating digital interventions to promote behavior change in health and health care: recommendations resulting from an international workshop. J Med Internet Res. 2017;19(6):e232.
- Guo C, Ashrafian H, Ghafur S, et al. Challenges for the evaluation of digital health solutions – A call for innovative evidence generation approaches. NPJ Digit Med. 2020;3:110.
- Riley WT, Glasgow RE, Etheredge L, et al. Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med. 2013;2(1):10.
- Pham Q, Wiljer D, Cafazzo JA. Beyond the Randomized Controlled Trial: a review of alternatives in mHealth clinical trial methods. JMIR Mhealth Uhealth. 2016;4(3):e107.
- Eysenbach G. The law of attrition. J Med Internet Res. 2005;7(1):e11.
- Baumel A, Muench F, Edan S, et al. Objective user engagement with mental health apps: systematic search and panel-based usage analysis. J Med Internet Res. 2019;21(9):e14567.
- Duan H, Wang Z, Ji Y, et al. Using goal-directed design to create a mobile health app to improve patient compliance with hypertension self-management: development and deployment. JMIR Mhealth Uhealth. 2020;8(2):e14466.
- Joiner KA, Lusch RF. Evolving to a new service-dominant logic for health care. Innovation Entrepreneurship Health. 2016;3:25–33.
- Greenhalgh T, Russell J. Why do evaluations of eHealth programs fail? An alternative set of guiding principles. PLoS Med. 2010;7(11):e1000360.
- IEEE Spectrum. BlueStar, the first prescription-only app. 2014 [cited 2020 Dec 29]. Available from: https://spectrum.ieee.org/biomedical/devices/bluestar-the-first-prescriptiononly-app
- Quinn CC, Clough SS, Minor JM, et al. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008;10(3):160–168.
- Quinn CC, Shardell MD, Terrin ML, et al. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34(9):1934–1942.
- Agarwal P, Mukerji G, Desveaux L, et al. Mobile app for improved self-management of type 2 diabetes: multicenter pragmatic randomized controlled trial. JMIR Mhealth Uhealth. 2019;7(1):e10321.
- Kolasa K, Goettsch W, Petrova G, et al. Without data, you’re just another person with an opinion. Expert Rev Pharmacoecon Outcomes Res. 2020;20(2):147–154.
- Gerke S, Stern AD, Minssen T. Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries. NPJ Digit Med. 2020;3:94.
- Iribarren SJ, Cato K, Falzon L, et al. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2):e0170581.
- The Lancet. Is digital medicine different? Lancet. 2018;392(10142):95.
- Catwell L, Sheikh A. Evaluating eHealth interventions: the need for continuous systemic evaluation. PLoS Med. 2009;6(8):e1000126.
- Innovation Eye [Internet]. Global mHealth industry landscape overview 2020. 2020 Sep [cited 2021 Jan 10]. Available from: http://analytics.dkv.global/global-mhealth-industry-2020/report.pdf
- Research2guidance [Internet]. mHealth economics 2016 – current status and trends of the mHealth app market. 2016 Oct [cited 2021 Jan 10]. Available from: http://research2guidance.com/r2g/r2g-mHealth-App-Developer-Economics-2016.pdf
- European Commission [Internet]. Recovery plan for Europe [cited 2021 Jan 08]. Available from: https://ec.europa.eu/info/strategy/recovery-plan-europe_en
- National Institute for Health and Care Excellence. Evidence standards framework for digital health technologies. 2019 [cited 2020 Dec 29]. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/evidence-standards-framework/digital-evidence-standards-framework.pdf
- Moshi MR, Tooher R, Merlin T. Suitability of current evaluation frameworks for use in the health technology assessment of mobile medical applications: a systematic review. Int J Technol Assess Health Care. 2018;34(5):464–475.
- International Telecommunication Union (ITU). ITU ICT eye: ICT data portal. 2020 [cited 2021 Jan 10]. Available from: https://www.itu.int/net4/ITU-D/icteye/#/query
- Wright A, Salazar A, Mirica M, et al. The invisible epidemic: neglected chronic disease management during COVID-19. J Gen Intern Med. 2020;35(9):2816–2817.
- Chudasama YV, Gillies CL, Zaccardi F, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020;14(5):965–967.
- Serlachius A, Badawy SM, Thabrew H. Psychosocial challenges and opportunities for youth with chronic health conditions during the COVID-19 pandemic. JMIR Pediatr Parent. 2020;3(2):e23057.
- Ramsetty A, Adams C. Impact of the digital divide in the age of COVID-19. J Am Med Inform Assoc. 2020;27(7):1147–1148.